Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline.
Neuroscience July 1, 1993 DOI: 10.1016/0306-4522(93)90500-f via PubMed
Summary
AI-generated from the abstractThe psychoactive compounds ibogaine and harmaline, both beta-carboline derivatives known to cause hallucinations and tremor, can damage specific neurons in the cerebellum. In rats, a single treatment with either drug led to the degeneration of Purkinje cells in narrow, striped regions of the cerebellar vermis, as shown by loss of specific neuronal proteins and silver staining of dying cells. The damage was confined to parasagittal stripes, matching the organization of climbing fiber inputs from the inferior olive. The authors conclude that both drugs have selective neurotoxic effects on Purkinje cells and suggest that sustained activation of inferior olivary neurons may cause excitotoxic degeneration via release of an excitatory amino acid from climbing fiber terminals.
Study at a glance
| Characteristics | Experimental animal study Longitudinal Peer reviewed |
|---|---|
| Population | Ibogaine- or harmaline-treated rats |
| Interventions | Ibogaine Harmaline |
| Citations | 220 |
| Key finding | Ibogaine and harmaline cause selective degeneration of Purkinje cells in parasagittal stripes of the cerebellar vermis in rats. |
Abstract
The indole alkaloids ibogaine and harmaline are beta-carboline derivatives that cause both hallucinations and tremor. Reports that ibogaine may have potent anti-addictive properties have led to initiatives that it be tested for the treatment of opiate and cocaine addiction. In this study, ibogaine-treated rats were analysed for evidence of neurotoxic effects because human clinical trials of ibogaine have been proposed. We recently found that ibogaine induces a marked glial reaction in the cerebellum with activated astrocytes and microglia aligned in parasagittal stripes within the vermis. Based on those findings, the present study was conducted to investigate whether ibogaine may cause neuronal injury or degeneration. The results demonstrate that, after treatment with ibogaine or harmaline, a subset of Purkinje cells in the vermis degenerates. We observed a loss of the neuronal proteins microtubule-associated protein 2 and calbindin co-extensive with loss of Nissl-stained Purkinje cell bodies. Argyrophilic staining of Purkinje cell bodies, dendrites and axons was obtained with the Gallyas reduced silver method for degenerating neurons. Degenerating neurons were confined to narrow parasagittal stripes within the vermis. We conclude that both ibogaine and harmaline have selective neurotoxic effects which lead to degeneration of Purkinje cells in the cerebellar vermis. The longitudinal stripes of neuronal damage may be related to the parasagittal organization of the olivocerebellar climbing fiber projection. Since these drugs produce sustained activation of inferior olivary neurons, we hypothesize that release of an excitatory amino acid from climbing fiber synaptic terminals may lead to excitotoxic degeneration of Purkinje cells.